- Home
- IMCC vs NTBL Comparison
IMCC vs NTBL Comparison
Compare IMCC & NTBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMCC
- NTBL
- Stock Information
- Founded
- IMCC 1980
- NTBL 2000
- Country
- IMCC Israel
- NTBL United States
- Employees
- IMCC N/A
- NTBL N/A
- Industry
- IMCC Medicinal Chemicals and Botanical Products
- NTBL Biotechnology: Pharmaceutical Preparations
- Sector
- IMCC Health Care
- NTBL Health Care
- Exchange
- IMCC Nasdaq
- NTBL Nasdaq
- Market Cap
- IMCC 5.0M
- NTBL 4.6M
- IPO Year
- IMCC N/A
- NTBL N/A
- Fundamental
- Price
- IMCC $2.23
- NTBL $0.25
- Analyst Decision
- IMCC
- NTBL Buy
- Analyst Count
- IMCC 0
- NTBL 2
- Target Price
- IMCC N/A
- NTBL $5.00
- AVG Volume (30 Days)
- IMCC 11.8K
- NTBL 8.1M
- Earning Date
- IMCC 11-11-2024
- NTBL 11-12-2024
- Dividend Yield
- IMCC N/A
- NTBL N/A
- EPS Growth
- IMCC N/A
- NTBL N/A
- EPS
- IMCC N/A
- NTBL N/A
- Revenue
- IMCC $36,445,402.00
- NTBL $313,000.00
- Revenue This Year
- IMCC $22.59
- NTBL N/A
- Revenue Next Year
- IMCC $20.53
- NTBL N/A
- P/E Ratio
- IMCC N/A
- NTBL N/A
- Revenue Growth
- IMCC N/A
- NTBL 3812.50
- 52 Week Low
- IMCC $1.13
- NTBL $0.22
- 52 Week High
- IMCC $8.10
- NTBL $4.24
- Technical
- Relative Strength Index (RSI)
- IMCC 41.06
- NTBL 35.14
- Support Level
- IMCC $2.02
- NTBL $0.28
- Resistance Level
- IMCC $2.15
- NTBL $0.37
- Average True Range (ATR)
- IMCC 0.14
- NTBL 0.06
- MACD
- IMCC -0.01
- NTBL -0.01
- Stochastic Oscillator
- IMCC 19.15
- NTBL 6.26
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.
About NTBL Notable Labs Ltd.
Notable Labs Ltd is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic. PPMP is designed to enable Notable to identify and select patients expected to be clinically responsive before the initiation of their treatment and potentially enable fast-track therapeutic development in this patient population.